Radiant Pain Relief Centres Announces Board of Directors
Business Wire - Tue May 05, 1:39PM CDT
Radiant Pain Relief Centres, which opened a pilot clinic in February 2014, announced that it established a board of directors this month as it moves forward in its plan to expand to more than 100 clinics in North America over the next five years. Board appointments include chairman Edward Brennan, Ph.D., a technology and healthcare entrepreneur; Thomas Rota, a Silicon Valley veteran; and P. Brendon Lundberg, president and CEO of Radiant. The two outside appointments were selected based on their experience with start-up companies, mergers and acquisitions, and corporate financing.
KRC: 71.01 (+0.02)
American Cryostem Announces Acquisition of Biolife Cell Bank
ACCESSWIRE - Mon Apr 20, 7:30AM CDT
EATONTOWN, NJ / ACCESSWIRE / April 20, 2015 / American CryoStem Corporation (PINKSHEETS: CRYO), a leading strategic developer, marketer and global licensor of patented adipose tissue-based cellular technologies for the Regenerative and Personalized Medicine industries, today announced the acquisition of Biolife Cell Bank's (Biolife) adipose tissue and adipose derived stem cell banking services assets.
American CryoStem Enters Into Definitive Term Sheet With Health Innovative Technology Corporation Limited
GlobeNewswire - Wed Jul 02, 8:57AM CDT
American CryoStem Corporation (OTCQB:CRYO), a leading strategic developer, marketer and global licensor of patented adipose tissue-based cellular technologies for the Regenerative and Personalized Medicine industries, today announced that it has made a major step in establishing a global footprint for its cellular technology and laboratory processing platform by entering into an agreement to license its ATGRAFT(TM) adipose tissue (fat) processing and storage technologies with Health Innovative Technology Corporation Limited (HIT), a Hong Kong corporation. HIT currently operates a cellular processing and banking platform and a chain of medical centers, offering comprehensive healthcare solutions to clients in Hong Kong.
American CryoStem Announces Agreement With the nanoRANCH Division of UHV Technologies for Cancer Research Utilizing ATCELL(TM)
GlobeNewswire - Wed Jun 18, 9:17AM CDT
American CryoStem Corporation (OTCQB:CRYO), a leading strategic developer, marketer and global licensor of patented adipose tissue-based cellular technologies for the Regenerative and Personalized Medicine industries, today announced that the Company has entered into initial agreements with the nanoRANCH Division of UHV Technologies, Inc. ("nanoRANCH"